Abbott Laboratories voluntarily withdraws its obesity drug Meridia

Abbott Laboratories voluntarily withdraws its obesity drug Meridia from market

Abbott Laboratories is voluntarily withdrawing its obesity drug Meridia (sibutramine) from the U.S. market since it is found from the data from the clinical trial that there is an increased risk of heart attack and strok .
Physicians are also advised not to prescribe drug Meridia to their patients. Patients are also requested to stop taking this medication as well. Patients requiring weight loss drug and currently on Meridia must talk to their health care provider for an alternative weight loss and weight loss maintenance programs.”

In November 1997 Meridia was approved by the US FDA for weight loss and maintenance of weight loss in obese people, and for certain overweight peoples having high risks for getting heart disease.
US FDA had approved Meridia drug containing active ingredient sibutramine , based on clinical trial data out come findings . About five percent of weight was lost compared to their body weight was observed in peoples who received sibutramine as compared to peoples people on placebo who relied on diet and exercise alone.

US FDA had requested the to withdraw Drug Meridia from market after reviewing data from the Sibutramine Cardiovascular Outcomes Trial (SCOUT). Sibutramine Cardiovascular Outcomes Trial SCOUT was carried out as requirement of post market drug safety monitoring study to assess cardiovascular safety of sibutramine after the European approval of this drug.

Results of clinical trial in a group of patients given sibutramine compared to another given placebo ,showed an increase by 16 percent in risk of getting serious heart events including non-fatal heart attack, non-fatal stroke, and the requirements of being resuscitated once the heart stopped, and death,. It was found that there is a little difference in weight loss between the placebo group and the group that received sibutramine as well.

=====================================================================================================
Do you know now this website has become a most popular and most referred website in pharmaceutical industry and pharmaceutical companies and pharmaceutical manufacturers from all over the world ,for almost all topics related to Pharmaceutical Manufacturing , Pharmaceutical Regulatory Affairs and Good Manufacturing Practice for Pharmaceutical Manufacturing (c GMP guidelines ) and latest news and new drugs developments.

=====================================================================================================
You may also like following articles

Whar is Referance Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents


Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic resitance and Antibiotic resistance mechanism

Antioxidants food suppliments

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing

Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Cleen Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detaied information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates

Here is an interesting article on world wide pharmaceutical industry and making a carrier in one of pharmaceutical companies article on Pharmaceutical Industry pharmaceutical industry

Find a Job in Pharmaceutical Company
To Find Pharmaceutical jobs and make a Pharmaceutical careers see here pharmaceutical companies
Here are some interesting articles on Quality assurance systems for pharmaceutical company

1.Quality assurance in pharma industry

2.Quality by designe concept for pharmaceutical industry

3.Quality by designe concept in pharmaceutical industryan explanation